Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summary. - Huang, Yuanbin; Ma, Xinmiao; Zhu, Hengxing; Shen, Chen; Hu, Ke; Yu, Yang; Yang, Aoyu; Liu, Zhuo; Liu, Chuanyang; Shi, Wenrui; Wang, Wei; Xia, Xueyan; et al. (Frontiers in Immunology, 2025)